Normal view MARC view ISBD view

Genetic Evolution And Development Of Recombinant Vaccine Against Newcastle Disease For Chicken In Pakistan

By: Abdul Wajid (2009-VA-705) | Dr. Muhammad Wasim.
Contributor(s): Prof. Dr. Tahir Yaqub | Dr. Muhammad Tayyab.
Material type: materialTypeLabelBookPublisher: 2017Description: 144p.Subject(s): Molecular Biology and Biotechnology | Phd. ThesisDDC classification: 2910-T Dissertation note: Newcastle disease (ND) is one of the most contagious diseases of poultry worldwide. The disease is endemic in Pakistan and recurrent outbreaks have been reported in commercial poultry flocks, domestic pet and migratory birds since 1963 an inception of commercial poultry farming in the country. Disease surveillance is necessary to determine the incidence of the disease as well as to identify the etiological agent of the disease status in the region. The analysis of the field data provides a clue for the higher authorities to take steps for the remedy of the devastating outbreak. A virulent form of Newcastle disease virus caused an outbreak in the northern region of Pakistan during the mid of 2011. The virus was identified as a virulent viscerotropic vvNDV and characterize, belonging to the sub genotype VIIi. However, the virus of this genotype is still circulating in the field though the intensity of the strain to succumb the chickens to cause mortality does not exist. The particular thing in this genotype was its susceptibility to other avian species like pheasants, peafowls, ducks turkeys, peacocks, sparrows and parakeets. As this genotype is circulating since 2011 2016 and still spill over in these avian species. Thus for the last five years (2011-16), 3500 healthy, diseased and dead chickens, pheasants, peacocks, turkeys, peafowls, ducks, sparrows, exotic parakeets, rosy-faced parrots, pigeons, and partridges from 750 different locations s were monitored. Samples were collected from the Northern region of the country Punjab, Khyber Pakhtoonkhawa, Azad Kashmir, including Gilgit,Baltitssan and from Southern region, Karachi, Hyderabad , Mirpursakro and other small cities where the poultry farms are located. The samples were collected by the local veterinarians, poultry Assistants and Animal health practitioners who assist during the surveillance program. Samples were also collected from the farmers who brought their birds for inspection in the lab with the details of the 141 farm. Mostly sampling was done where there was reports of NDV outbreak, tissues were collected usually the trachea, spleen and brain, moreover, the pharyngeal and cloacal swabs not only from the infected birds but also from the healthy birds were collected to assess the virus shedding in the flock. Blood samples were also collected (1% of the birds at farm), for serum collection to assess the immune status of the flock using Haemagglutination Inhibition (HI) test and Enzyme linked immunosorbant assay (ELISA). The Survey Form meet the international standard was filled for each farm for recording the information required to find the diagnostic clue as well as the molecular characterization of the isolates. Pool of five pharyngeal swabs were processed after the passage into 9-day old chicken embryonated eggs and confirming the positive HA test and then confirmed by real time PCR (RT-PCR). In addition, sera were tested against NDV by HI and ELISA tests. The targeted samples were sequenced by complete fusion gene and whole genome using 22 pairs of overlapping primers. The observations indicated that the commercial broiler industry is highly susceptible to virulent NDV and confirmed by data available in the laboratory in the survey form. Contrary to that a little is known regarding the maintenance and enzootic trends of vNDV infection level in domestic and wild birds. Poor strategy of the use of vaccines and vaccination as well as the existence of virulent form of NDV in the domestic and pet birds indicate a possibility of the root cause of the ND eruption in the developing countries. A continuous isolation of virulent viruses of the panzootic Newcastle disease virus of sub-genotype VIIi since (2011-2016 from commercial chickens and from various other avian species in the country provide evidence for the existence of epidemiological links intermingling of the strain among them. Therefore, to avoid the huge economical losses in the commercial poultry the second largest industry in Pakistan, their close proximity should be strictly avoided. The mass vaccination of the poultry flocks is in practice in all commercial 142 poultry farms in Pakistan. However, the use and availability of a reliable and standard vaccine, as well as the correct usage of vaccine dose of the live attenuated LaSota vaccine are the key factors to improve their efficacy in the field. Minor outbreaks have been occurring in the field even though a severe outbreak was occurred in 2011-12 collapsed the poultry industry with other pet and wild birds. To minimize the continuity of these minor outbreaks in the field for long time there is a need for more effective vaccine to control the particular genotype of the ND virus. In the present study, DNA vaccine was developed using the SFR-55 NDV strain antigens, in the form of fusion (F) and hemagglutinin-neuroaminidase (HN), namely pcDNA3.1-F and pcDNA3.1-HN. In vitro expression of both genes construct was assessed by reversetranscriptase- PCR (RT-PCR) and western blotting. In the trial an inactivated oil-based emulsion vaccine was prepared using the field strain SFR-55 and compare with the commercial vaccine LaSota strain commonly used by the poultry industry. Birds were divided into six groups, the first two groups were immunized with pcDNA3.1-F and pcDNA3.1-HN alone respectively and third group with was vaccinated with both antigens pcDNA3.1-F+HN. The other two groups were immunized with inactivated (wvSFR-55) and LaSota vaccines as described above, the last group was injected with empty vector as control. The birds were immunized twice at 14 and 21 days of age intramuscularly (DNA vaccine), subcutaneous and eye-drop by inactivated and LaSota vaccines respectively. The birds were challenged with live virulent NDV strain using a dose of 10,000 ELD50/0.1ml per chicken. Results indicate that Inactivated and LaSota vaccines provided high protection (>80%), as compared to pcDNA3.1-F, pcDNA3.1-HN, pcDNA3.1- F+HN gave 70%, 75% and 20% respectively. There was 100% mortality in control chickens. The administration of two vectors expressing F and HN antigens induced high immune response, and provide protection than when used separately. However, the groups immunized with 143 pcDNA3.1-F, pcDNA3.1-F+HN and inactivated vaccine resulted in lower amount of virulent virus shed after challenge when compared to the group immunized with standard LaSota. In summary, the co-administration of both NDV glycoprotein antigens increased protection than use separately. DNA-based vaccine can be used safely to reduce mortality and most importantly lower the risk of virus transmission due to decreased level of virulent virus shedding.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Collection Call number Status Date due Barcode Item holds
Thesis Thesis UVAS Library
Thesis Section
Veterinary Science 2910-T (Browse shelf) Available 2910-T
Total holds: 0

Newcastle disease (ND) is one of the most contagious diseases of poultry worldwide. The
disease is endemic in Pakistan and recurrent outbreaks have been reported in commercial poultry
flocks, domestic pet and migratory birds since 1963 an inception of commercial poultry farming
in the country. Disease surveillance is necessary to determine the incidence of the disease as well
as to identify the etiological agent of the disease status in the region. The analysis of the field
data provides a clue for the higher authorities to take steps for the remedy of the devastating
outbreak. A virulent form of Newcastle disease virus caused an outbreak in the northern region
of Pakistan during the mid of 2011. The virus was identified as a virulent viscerotropic vvNDV
and characterize, belonging to the sub genotype VIIi. However, the virus of this genotype is still
circulating in the field though the intensity of the strain to succumb the chickens to cause
mortality does not exist. The particular thing in this genotype was its susceptibility to other avian
species like pheasants, peafowls, ducks turkeys, peacocks, sparrows and parakeets. As this
genotype is circulating since 2011 2016 and still spill over in these avian species. Thus for the
last five years (2011-16), 3500 healthy, diseased and dead chickens, pheasants, peacocks,
turkeys, peafowls, ducks, sparrows, exotic parakeets, rosy-faced parrots, pigeons, and partridges
from 750 different locations s were monitored. Samples were collected from the Northern region
of the country Punjab, Khyber Pakhtoonkhawa, Azad Kashmir, including Gilgit,Baltitssan and
from Southern region, Karachi, Hyderabad , Mirpursakro and other small cities where the poultry
farms are located. The samples were collected by the local veterinarians, poultry Assistants and
Animal health practitioners who assist during the surveillance program. Samples were also
collected from the farmers who brought their birds for inspection in the lab with the details of the
141
farm. Mostly sampling was done where there was reports of NDV outbreak, tissues were
collected usually the trachea, spleen and brain, moreover, the pharyngeal and cloacal swabs not
only from the infected birds but also from the healthy birds were collected to assess the virus
shedding in the flock. Blood samples were also collected (1% of the birds at farm), for serum
collection to assess the immune status of the flock using Haemagglutination Inhibition (HI) test
and Enzyme linked immunosorbant assay (ELISA). The Survey Form meet the international
standard was filled for each farm for recording the information required to find the diagnostic
clue as well as the molecular characterization of the isolates. Pool of five pharyngeal swabs were
processed after the passage into 9-day old chicken embryonated eggs and confirming the positive
HA test and then confirmed by real time PCR (RT-PCR). In addition, sera were tested against
NDV by HI and ELISA tests. The targeted samples were sequenced by complete fusion gene and
whole genome using 22 pairs of overlapping primers. The observations indicated that the
commercial broiler industry is highly susceptible to virulent NDV and confirmed by data
available in the laboratory in the survey form. Contrary to that a little is known regarding the
maintenance and enzootic trends of vNDV infection level in domestic and wild birds. Poor
strategy of the use of vaccines and vaccination as well as the existence of virulent form of NDV
in the domestic and pet birds indicate a possibility of the root cause of the ND eruption in the
developing countries. A continuous isolation of virulent viruses of the panzootic Newcastle
disease virus of sub-genotype VIIi since (2011-2016 from commercial chickens and from various
other avian species in the country provide evidence for the existence of epidemiological links
intermingling of the strain among them. Therefore, to avoid the huge economical losses in the
commercial poultry the second largest industry in Pakistan, their close proximity should be
strictly avoided. The mass vaccination of the poultry flocks is in practice in all commercial
142
poultry farms in Pakistan. However, the use and availability of a reliable and standard vaccine, as
well as the correct usage of vaccine dose of the live attenuated LaSota vaccine are the key factors
to improve their efficacy in the field. Minor outbreaks have been occurring in the field even
though a severe outbreak was occurred in 2011-12 collapsed the poultry industry with other pet
and wild birds. To minimize the continuity of these minor outbreaks in the field for long time
there is a need for more effective vaccine to control the particular genotype of the ND virus. In
the present study, DNA vaccine was developed using the SFR-55 NDV strain antigens, in the
form of fusion (F) and hemagglutinin-neuroaminidase (HN), namely pcDNA3.1-F and
pcDNA3.1-HN. In vitro expression of both genes construct was assessed by reversetranscriptase-
PCR (RT-PCR) and western blotting. In the trial an inactivated oil-based emulsion
vaccine was prepared using the field strain SFR-55 and compare with the commercial vaccine
LaSota strain commonly used by the poultry industry. Birds were divided into six groups, the
first two groups were immunized with pcDNA3.1-F and pcDNA3.1-HN alone respectively and
third group with was vaccinated with both antigens pcDNA3.1-F+HN. The other two groups
were immunized with inactivated (wvSFR-55) and LaSota vaccines as described above, the last
group was injected with empty vector as control. The birds were immunized twice at 14 and 21
days of age intramuscularly (DNA vaccine), subcutaneous and eye-drop by inactivated and
LaSota vaccines respectively. The birds were challenged with live virulent NDV strain using a
dose of 10,000 ELD50/0.1ml per chicken. Results indicate that Inactivated and LaSota vaccines
provided high protection (>80%), as compared to pcDNA3.1-F, pcDNA3.1-HN, pcDNA3.1-
F+HN gave 70%, 75% and 20% respectively. There was 100% mortality in control chickens.
The administration of two vectors expressing F and HN antigens induced high immune response,
and provide protection than when used separately. However, the groups immunized with
143
pcDNA3.1-F, pcDNA3.1-F+HN and inactivated vaccine resulted in lower amount of virulent
virus shed after challenge when compared to the group immunized with standard LaSota. In
summary, the co-administration of both NDV glycoprotein antigens increased protection than
use separately. DNA-based vaccine can be used safely to reduce mortality and most importantly
lower the risk of virus transmission due to decreased level of virulent virus shedding.

There are no comments for this item.

Log in to your account to post a comment.


Implemented and Maintained by UVAS Library.
For any Suggestions/Query Contact to library or Email:rehana.kousar@uvas.edu.pk Phone:+91 99239068
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.